| Saturday, October 24, 2009 |
| 7:00 AM–6:30 PM |
|
| |
Registration |
|
|
| 8:00 AM–12:05 PM |
|
| |
Saturday Workshop 1
Bacterial Mutagenicity Screening for Discovery Support and Drug Candidate Selection
Separate Registration Required
Contributing Sponsor : sanofi aventis
|
Organized by: New Technologies Special Interest Group
Chairpersons: Patricia A. Escobar, Boehringer Ingelheim Pharmaceuticals and Brinda Mahadevan, Schering-Plough Research Institute |
| 8:00 AM–8:05 AM |
Introduction
Patricia A. Escobar, Boehringer Ingelheim Pharmaceuticals |
| 8:05 AM–8:30 AM |
Mini-Ames Assay in Six Well Plates
Speaker: John J. Nicolette, Abbott Laboratories |
| 8:30 AM–8:55 AM |
Cross-Validation Results from the Miniaturized Ames Studies
Speaker: Satin G. Sawant, Amgen, Inc. |
| 8:55 AM–9:20 AM |
Bacterial Mutagenicity Screening Technology (BioLum Ames)
Speaker: Michelle Kenyon, Pfizer, Global Research and Development |
| 9:20 AM–9:45 AM |
The Merck Experience with the Ames MPF Assay and its Correlation with the Standard Ames and the 5-Fluorouracil (FU) Assay
Speaker: Timothy E. Johnson, Merck Research Laboratories
|
| 9:45 AM–10:10 AM |
The Use of Ames II ™ Screening Assay for Drug Development
Speaker: Knut Braun, sanofi aventis |
| 10:10 AM–10:25 AM |
Break
|
| 10:25 AM–10:50 AM |
Performance of the SOS Chromotest as an Initial Mutagenicity Screen
Speaker: Laura L. Custer, Bristol-Myers Squibb |
| 10:50 AM–11:15 AM |
The SOS/umu Test: Experience Screening Pharmaceutical Research Compounds
Speaker: Michael O’Donnavan, AstraZenca
|
| 11:15 AM–11:35 AM |
Summary of the Case Studies
Speaker: Brinda Mahadevan, Schering-Plough Research Institute
|
| 11:35 AM–12:05 PM |
Panel Discussion /Concluding Remarks
Moderator: Sheila M. Galloway, Merck Research Laboratories
|
|
| 10:00 AM–12:30 PM |
|
| |
EMS Executive Board Meeting |
|
|
|
| 1:00 PM–4:30 PM |
|
| |
EMS Council Meeting |
|
|
| 1:00 PM–4:30 PM |
|
| |
Saturday Workshop 2
Gene Mutation Assays Based on the Endogenous Pig-A Locus
Separate Registration Required
Contributing Sponsors: ILSI-HESI, Project Committee on Relevance and Follow-up of Positive Results in In Vitro Genetic Toxicity (IVGT) Testing, Litron Laboratories, and sanofi aventis |
Chairpersons: Stephen D. Dertinger, Litron Laboratories and Robert H. Heflich, National Center for Toxicological Research, U.S. FDA |
| 1:00 PM–1:05 PM |
Welcome
Speakers: Stephen D. Dertinger, Litron Laboratories and Robert H. Heflich, National Center for Toxicological Research, U.S. FDA |
| 1:05 PM–1:30 PM |
Historical Perspective: From Studying PNH Etiology to Mutagenesis
Speaker: Russell E. Ware, St. Jude Children’s Research Hospital |
| 1:30 PM–2:00 PM |
Gene Mutation Assays Based on the Endogenous Pig-A Locus: Rodent Mutation Data, Kinetics, DNA Sequencing Results
Speaker: Daishiro Miura,TEIJIN Pharma Limited |
| 2:00 PM–2:30 PM |
Rodent RBC-Based Assay, Inter-Laboratory Trial Update
Speakers: Stephen D. Dertinger, Litron Laboratories and Ronald D. Fiedler, Pfizer Global Research & Development |
| 2:30 PM–2:45 PM |
ILSI-HESI Perspective on Assay’s Preclinical Value
Speaker: James H. Kim, ILSI Health and Environmental Sciences Institute |
| 2:45 PM–3:00 PM |
Break
|
| 3:00 PM–3:30 PM |
Human Blood-Based Assay, RBCs
Speaker: Vasily N. Dobrovolsky, National Center for Toxicological Research, U.S. FDA |
| 3:30 PM–4:00 PM |
PIGA: A Novel Reporter Gene for the Molecular Epidemiology of Cancer
Speaker: Vernon E. Walker, BioMosaics Inc. |
| 4:00 PM–4:30 PM |
Panel Discussion |
| |
| 4:45 PM–6:00 PM |
|
| |
Plenary Lecture 1
National Science Education Policy (40th Anniversary Event)
|
Chairperson: Michael J. Plewa, University of Illinois at Urbana-Champaign |
| 4:45 PM–5:00 PM |
Introductory Comments
Speaker: Michael J. Plewa, University of Illinois at Urbana-Champaign |
| 5:00 PM–6:00 PM |
Rising Above the Gathering Storm: Scientific Societies Must Meet the Challenge
Speaker: James M. Gentile, Research Corporation for Science Advancement |
| |
| 6:00 PM–7:30 PM |
|
| |
Welcome Reception and Student and New Investigator Poster Session
Contributing Sponsor: Genetic Toxicology Association
|
|
|